Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

ABSTRACT: RATIONALE: Studying samples of blood and urine in the laboratory from patients with cancer receiving bevacizumab may help doctors learn more about changes that occur in DNA and identify biomarkers related to high blood pressure. PURPOSE: This phase I trial is studying potential biomarkers for bevacizumab-induced high blood pressure in patients with malignant solid tumors, including breast cancer, colorectal cancer, non-small cell lung cancer, head and neck cancer, ovarian cancer, fallopian tube cancer, or primary peritoneal carcinoma.

DISEASE(S): Lung Cancer,Colorectal Cancer,Fallopian Tube Cancer,Head And Neck Neoplasms,Breast Neoplasms,Lung Neoplasms,Breast Cancer,Cardiovascular Complications,Unspecified Adult Solid Tumor, Protocol Specific,Ovarian Cancer,Fallopian Tube Neoplasms,Peritoneal Cavity Cancer,Head And Neck Cancer

PROVIDER: 2087045 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Gene expression analysis of ovarian tumors from mice with knockout of DICER and PTEN

Project description:The cell of origin of serious ovarian cancer is unknown. To create a mouse model for this lethal cancer and identify early cancer biomarkers, we conditionally deleted both Dicer (essential for microRNA biosynthesis) and Pten (a negative regulator of the PI3K pathway) in the female reproductive tract. Beginning at ~3-5 months, these Dicer/Pten mutant mice develop high-grade serious carcinomas that initiate in the stroma of the fallopian tube through a mesenchymal-to-epithelial transition (MET), subsequently envelop the ovary, and then metastasize throughout the peritoneum, resulting in ascites and 100% lethality by 13 months. The fallopian tube cancers demonstrate upregulation of genes encoding known and novel secreted proteins that are potential biomarkers. This study uncovers a new paradigm for the initiation of high-grade serous ovarian cancer. RNA was isolated from the fallopian tube cancers of independent DKO mice and normal fallopian tubes of control mice and subjected to mRNA expression analysis using an Illumina platform (MouseWG-6 v2 Expression BeadChip).

2012-02-16 | E-GEOD-28720 | biostudies-arrayexpress

Hypothalamic expression differences between hypertensive BPH/2J during circadian variations of blood pressure

2011-04-04 | GSE26007 | GEO

high-pressure enrichment

Project description:high-pressure enrichment Raw sequence reads

| PRJNA797264 | ENA

Perirenal Adipose Afferent Nerves Sustain Pathological High Blood Pressure

Project description:Perirenal Adipose Afferent Nerves Sustain Pathological High Blood Pressure

| PRJNA674829 | ENA

Hypothalamic expression differences between hypertensive BPH/2J during circadian variations of blood pressure

Project description:Identification of hypothalamic genes whose expression differs between active (peak of blood pressure) and inactive periods in the high blood pressure (BPH/2J) Schlager mouse, adjusted by their age- and activity-matched normal blood pressure (BPN/3J) controls using Affymetrix GeneChip® Mouse Gene 1.0 ST Arrays. The whole hypothalamus was removed from BPH/2J and age-matched BPN/2J (n=3/group, 19 week old, ‘trough’ blood pressure) in the inactive period, when the blood pressure levels of the BPH/2J and BPN/3J models are similar. Hypothalamus of BPH/2J and age-matched BPN/2J (n=6/group, 26 week old, ‘peak’ blood pressure) were collected on the same way at the peak of the circadian variation, when there blood pressure difference between the strains was maximal. No pooling was performed. After extraction of RNA, cRNA was prepared and arrays performed using Affymetrix GeneChip® Mouse Gene 1.0 ST Arrays performed at the Ramaciotti Gene Function Analysis facility, University of New South Wales in Sydney, Australia.

2011-04-04 | E-GEOD-26007 | biostudies-arrayexpress

Regulatory variants of blood pressure genes

Project description:Regulatory variants of blood pressure genes

| PRJNA881331 | ENA

Gene expression analysis of human serious ovarian tumors and fimbria control

Project description:The cell of origin of serious ovarian cancer is unknown. To create a mouse model for this lethal cancer and identify early cancer biomarkers, we conditionally deleted both Dicer (essential for microRNA biosynthesis) and Pten (a negative regulator of the PI3K pathway) in the female reproductive tract. Beginning at ~3-5 months, these Dicer/Pten mutant mice develop high-grade serious carcinomas that initiate in the stroma of the fallopian tube through a mesenchymal-to-epithelial transition (MET), subsequently envelop the ovary, and then metastasize throughout the peritoneum, resulting in ascites and 100% lethality by 13 months. The fallopian tube cancers demonstrate upregulation of genes encoding known and novel secreted proteins that are potential biomarkers. This study uncovers a new paradigm for the initiation of high-grade serous ovarian cancer. We generated gene expression profiles of 8 human primary serious tumors, and 2 independent samples of human normal fimbria. We defined genes that were high or low in tumors relative to fimbria, and compared these results with those of the correponding mouse model.

2012-02-16 | E-GEOD-28721 | biostudies-arrayexpress

Regulatory variants of blood pressure genes

Project description:Genome-wide association studies (GWAS) have identified blood pressure-related loci, but functional insights into causality and related molecular mechanisms lag behind. We functionally characterize 4608 genetic variants in linkage with blood pressure loci in vascular smooth muscle cells (VSMCs) and cardiomyocytes (CMs) by massively parallel reporter assays (MPRAs). Regulatory variants are in non-conserved loci, enriched in repeats, and alter trait-relevant transcription factor binding sites. Higher-order genome organization indicates that loci harboring regulatory variants converge in spatial hubs to control specific signaling pathways required for proper cardiovascular function. Modelling different variant allele frequencies by CRISPR prime editing led to expression changes of KCNK9, SFXN2, and PCGF6. We provide mechanistic insights into how regulatory variants converge their effects on blood pressure genes (i.e. ULK4, MAP4, CFDP1, PDE5A, 10q24.32), and cardiovascular pathways. Our findings support advances in molecular precision medicine to define functionally relevant variants and the genetic architecture of blood pressure genes.

2023-04-25 | GSE213558 | GEO

Systolic Blood Pressure Intervention Trial (SPRINT-BioLINCC)

Project description:Systolic Blood Pressure Intervention Trial (SPRINT-BioLINCC)

| PRJNA1047942 | ENA

Systolic Blood Pressure Intervention Trial (SPRINT-Imaging)

Project description:Systolic Blood Pressure Intervention Trial (SPRINT-Imaging)

| PRJNA1079434 | ENA